Vaccine News and Research

Latest Vaccine News and Research

Hybrid immunity retained six months after SARS-CoV-2 exposure

Scientists hypothesize that lower death rates in COVID-19 patients may be due to hybrid immunity, as well as the reduced severity of Omicron infections.

3 Aug 2022

Queen’s researchers receive grant from Breast Cancer Now to search for new treatments

Researchers at Queen's University Belfast have received funding from Breast Cancer Now to search for new treatments inspired by COVID-19 vaccine innovation.

3 Aug 2022

UCI researchers develop novel test that detects specific SARS-CoV-2 variants with 100% accuracy

University of California, Irvine researchers have developed a COVID-19 test that detects and identifies specific SARS-CoV-2 variants with 100% accuracy.

3 Aug 2022

Lower efficacy of COVID-19 mRNA vaccines in patients with frailty

In a new study, researchers assessed the effectiveness of COVID-19 vaccination against hospitalization and deaths among veterans based on frailty status in the United States.

3 Aug 2022

Case series of first 3 monkeypox patients in Massachusetts treated with tecoviromat

A team of US-based scientists has described the therapeutic efficacy of a pan-Orthopoxvirus inhibitor, tecovirimat, in patients with monkeypox infection

3 Aug 2022

Memory B and T cell responses to the SARS-CoV-2 spike protein before and after the third BNT162b2 booster

Researchers evaluated memory B and T cell responses to SARS-CoV-2 before and after the third dose of the BNT162b2 vaccine.

3 Aug 2022

How effective is the recommendation of wearing glasses to protect against SARS-CoV-2 and other respiratory virus infection?

Researchers tested the effectiveness of wearing glasses in lowering the risk of contracting SARS-CoV-2 and other respiratory viral infections in community backdrop.

3 Aug 2022

Low neutralization of Omicron BA.5 after four doses of mRNA COVID-19 vaccine

Researchers assessed the neutralization of SARS-CoV-2 Omicron variant after messenger ribonucleic acid (mRNA) vaccination.

3 Aug 2022

The antibody evasion properties of the SARS-CoV-2 Omicron subvariant BA.2.75

Researchers evaluated all the features, especially the antigenic properties and transmission potential of SARS-CoV-2 Omicron sub-variant BA.2.75.

3 Aug 2022

Researchers implement standardized shunt infection prevention bundle within the adult population

Researchers at the University of Calgary, Alberta, Canada, investigated theimplementation of a standardized shunt infection prevention bundle, a set of evidence-based practices termed the Calgary Adult Shunt Infection Prevention Protocol (CASIPP) to prevent ventriculoperitoneal (VP) shunt infections within an adult hydrocephalus patient population. The initial implementation of the CASIPP resulted in infection reduction, and then the rate of infections was dramatically reduced after the preoperative skin antiseptic was replaced with 2% chlorhexidine gluconate in 70% isopropyl alcohol.

3 Aug 2022

Further SARS-CoV-2 variants, and intermittent epidemics may become the 'new normal'

A new study explores the dynamics of the SARS-CoV-2 Omicron and other variants circulating in England.

2 Aug 2022

COVID pandemic stress and menstrual cycle changes

A new study explores the effect of the COVID-19 pandemic on women’s reproductive health.

2 Aug 2022

LJI acquires Carterra LSA instrument to enhance antibody screening and characterization efforts

Carterra, Inc., the world leader in innovative technologies enabling high-throughput biology, and La Jolla Institute for Immunology, a globally recognized non-profit research organization dedicated to understanding the power of the immune system to promote human health, announced today that LJI has acquired a Carterra LSA instrument to enhance its antibody screening and characterization work.

2 Aug 2022

Vaccination and BA.1 breakthrough infection induce neutralizing antibodies less efficient against BA.4 and BA.5 Omicron variants

A new study aimed to describe the appearance of the Omicron variants in Israel, from March to June 2022, as well as the neutralizing antibody response against the primary Omicron subvariants.

2 Aug 2022

Adults aged ≥50 years boosted with SARS-CoV-2 mRNA vaccines less likely to experience adverse reactions after second booster than during initial booster

A new study monitored the safety of the second booster dose of SARS-CoV-2 messenger ribonucleic acid vaccination among those ≥50 Years.

2 Aug 2022

Study explores differential antibody-mediated effector functions evoked by two mRNA-based COVID-19 vaccines

Researchers evaluated the differential humoral immune response to two COVID-19 vaccines - messenger ribonucleic acid (mRNA)-1273 and BNT162b2.

2 Aug 2022

Pediatric adjuvant formulation offers protection against RSV in newborns

Respiratory syncytial virus (RSV) is the leading global cause of death in children under age 5 and lacks an effective vaccine. In a study from the Precision Vaccines Program at Boston Children's Hospital, a new vaccine formulation protected newborn mice against infection and evoked strong responses in immune cells from human newborns in the laboratory. Results were reported August 2 in Nature Communications.

2 Aug 2022

Researchers urge the need to amplify Indigenous-focused COVID-19 response measures

Despite prioritizing Indigenous populations for SARS-CoV-2 vaccinations, vaccine uptake was low among First Nations, Inuit and Métis Peoples in Toronto and London, Ontario, according to new research published in CMAJ (Canadian Medical Association Journal).

2 Aug 2022

How does Omicron BA.1 infection impact the risk of reinfection with BA.5?

Researchers found prior exposure to SARS-CoV-2 Omicron sub-variants BA.1/BA.2 reduced the risk of breakthrough infection by its sub-variant BA.5.

2 Aug 2022

What are the hidden sources of SARS-CoV-2 evolution?

A recent article published in Transplant Infectious Disease examined case reports on SARS-CoV-2 evolution in immunosuppressed cohorts.

2 Aug 2022

Vaccine News and Research

Latest Vaccine News and Research

Hybrid immunity retained six months after SARS-CoV-2 exposure

Queen’s researchers receive grant from Breast Cancer Now to search for new treatments

UCI researchers develop novel test that detects specific SARS-CoV-2 variants with 100% accuracy

Lower efficacy of COVID-19 mRNA vaccines in patients with frailty

Case series of first 3 monkeypox patients in Massachusetts treated with tecoviromat

Memory B and T cell responses to the SARS-CoV-2 spike protein before and after the third BNT162b2 booster

How effective is the recommendation of wearing glasses to protect against SARS-CoV-2 and other respiratory virus infection?

Low neutralization of Omicron BA.5 after four doses of mRNA COVID-19 vaccine

The antibody evasion properties of the SARS-CoV-2 Omicron subvariant BA.2.75

Researchers implement standardized shunt infection prevention bundle within the adult population

Further SARS-CoV-2 variants, and intermittent epidemics may become the 'new normal'

COVID pandemic stress and menstrual cycle changes

LJI acquires Carterra LSA instrument to enhance antibody screening and characterization efforts

Vaccination and BA.1 breakthrough infection induce neutralizing antibodies less efficient against BA.4 and BA.5 Omicron variants

Adults aged ≥50 years boosted with SARS-CoV-2 mRNA vaccines less likely to experience adverse reactions after second booster than during initial booster

Study explores differential antibody-mediated effector functions evoked by two mRNA-based COVID-19 vaccines

Pediatric adjuvant formulation offers protection against RSV in newborns

Researchers urge the need to amplify Indigenous-focused COVID-19 response measures

How does Omicron BA.1 infection impact the risk of reinfection with BA.5?

What are the hidden sources of SARS-CoV-2 evolution?

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in